​

Funding Round

Series B - Solarea Bio

Series B - Solarea Bio

Investment Firm

Overview

Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.

Announced Date

May 08, 2023

Closed on Date

May 08, 2023

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

S2G Ventures

S2G Ventures

S2G Ventures is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

4

Investor Name
Participant InvestorGG 1978
Participant InvestorViking Global Investors
Participant InvestorS2G Ventures
Participant InvestorBold Capital Partners

Round Details and Background

Solarea Bio raised $15000000 on 2023-05-08 in Series B

Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 17, 2018
Seed Round - Solarea Bio
2-undefined
Oct 19, 2020
Series A - Solarea Bio
4-11.2M
May 08, 2023
Series B - Solarea Bio
4-15.0M
Aug 23, 2023
Grant - Solarea Bio
1-undefined

Recent Activity

There is no recent news or activity for this profile.